Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70382 |
KBP-7018 HCl
|
||
KBP-7018 Hydrochloride is a novel, tyrosine kinase-selective inhibitor with potent effects on three fibrotic kinases (c-KIT, PDGFR, and RET). | |||
T70381 |
GSK2793660 free base
|
||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. |